These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19762535)

  • 1. Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors ("hematogones") and B lymphoblastic leukemia blasts.
    Hassanein NM; Alcancia F; Perkinson KR; Buckley PJ; Lagoo AS
    Am J Clin Pathol; 2009 Oct; 132(4):573-80. PubMed ID: 19762535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of CD34/CD123 expression in detection of minimal residual disease in B-ACUTE lymphoblastic leukemia in children.
    Zeidan MA; Kamal HM; El Shabrawy DA; Esh AM; Sattar RH
    Blood Cells Mol Dis; 2016 Jul; 59():113-8. PubMed ID: 27282579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
    Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.
    Muzzafar T; Medeiros LJ; Wang SA; Brahmandam A; Thomas DA; Jorgensen JL
    Am J Clin Pathol; 2009 Nov; 132(5):692-8. PubMed ID: 19846809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic analysis of bone marrow B lymphocyte precursors (hématogones) by flow cytometry.
    Braham Jmili N; Nsaibia S; Jacob MC; Omri H; Laatiri MA; Yacoub S; Braham Y; Aouni M; Kortas M
    Clin Lab Sci; 2009; 22(4):208-15. PubMed ID: 19967915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells.
    Gaipa G; Basso G; Aliprandi S; Migliavacca M; Vallinoto C; Maglia O; Faini A; Veltroni M; Husak D; Schumich A; Ratei R; Biondi A; Dworzak MN;
    Cytometry B Clin Cytom; 2008 May; 74(3):150-5. PubMed ID: 18271020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia.
    Hurford MT; Altman AJ; DiGiuseppe JA; Sherburne BJ; Rezuke WN
    Am J Clin Pathol; 2008 May; 129(5):700-5. PubMed ID: 18426728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.
    Seegmiller AC; Kroft SH; Karandikar NJ; McKenna RW
    Am J Clin Pathol; 2009 Dec; 132(6):940-9. PubMed ID: 19926587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.
    Muñoz L; Nomdedéu JF; López O; Carnicer MJ; Bellido M; Aventín A; Brunet S; Sierra J
    Haematologica; 2001 Dec; 86(12):1261-9. PubMed ID: 11726317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance.
    Zhi L; Wang M; Rao Q; Yu F; Mi Y; Wang J
    Cancer Lett; 2010 Oct; 296(1):65-73. PubMed ID: 20444543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.
    Al-Shieban S; Byrne E; Trivedi P; Morilla R; Matutes E; Naresh KN
    Br J Haematol; 2011 Aug; 154(4):466-70. PubMed ID: 21722099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome.
    Dakka N; Bellaoui H; Bouzid N; Khattab M; Bakri Y; Benjouad A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):216-31. PubMed ID: 19437324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZAP-70 and Bcl-2 expression in B lymphoblastic leukemia cells and hematogones.
    Craig FE; Monaghan SA; Surti U; Swerdlow SH
    Cytometry B Clin Cytom; 2012 Mar; 82(2):85-92. PubMed ID: 22031455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features.
    Rimsza LM; Larson RS; Winter SS; Foucar K; Chong YY; Garner KW; Leith CP
    Am J Clin Pathol; 2000 Jul; 114(1):66-75. PubMed ID: 10884801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotypic analysis of hematogones in patients with hematological malignancies].
    Kobayashi S; Kumagai R; Omiya A; Tanno H; Ishii Y; Yamamoto W; Takasaki H; Sakai R; Numata A; Matsumoto K; Tanaka M; Kanamori H; Motomura S; Maruta A
    Rinsho Ketsueki; 2012 Aug; 53(8):753-9. PubMed ID: 22975815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin.
    Gobbi G; Mirandola P; Malinverno C; Sponzilli I; Carubbi C; Ricci F; Binazzi R; Basso G; Giuliani-Piccari G; Ramazzotti G; Pasquantonio G; Cocco L; Vitale M
    Int J Oncol; 2008 Aug; 33(2):371-4. PubMed ID: 18636158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
    Al-Mawali A; Pinto AD; Al-Zadjali S
    Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.